Antifungal activity of silver salts of Keggin-type heteropolyacids against
Pathogenic fungus
antifungal effect
polyoxometalate
silver
zoonosis
Journal
Journal of microbiology and biotechnology
ISSN: 1738-8872
Titre abrégé: J Microbiol Biotechnol
Pays: Korea (South)
ID NLM: 9431852
Informations de publication
Date de publication:
28 Apr 2020
28 Apr 2020
Historique:
pubmed:
3
1
2020
medline:
30
12
2020
entrez:
3
1
2020
Statut:
ppublish
Résumé
Sporotrichosis is a chronic and subacute mycosis causing epidemiological outbreaks involving sick cats and humans in southeastern Brazil. The systemic disease prevails in cats, and in humans, the symptoms are restricted to skin in immunocompetent individuals. Under these conditions, the prolonged treatment of animals and cases of recurrence justify the discovery of new treatments for sporotrichosis. This work addresses the antifungal activity of silver salts of Keggin-type heteropolyacid salts (Ag-HPA salts) such as Ag
Identifiants
pubmed: 31893614
pii: 10.4014/jmb.1907.07064
doi: 10.4014/jmb.1907.07064
pmc: PMC9728368
doi:
Substances chimiques
Antifungal Agents
0
Salts
0
Tungsten Compounds
0
polyoxometalate I
0
Silver
3M4G523W1G
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
540-551Références
Antimicrob Agents Chemother. 2002 Aug;46(8):2668-70
pubmed: 12121953
Mycopathologia. 2013 Aug;176(1-2):129-37
pubmed: 23729233
PLoS Negl Trop Dis. 2014 Aug 28;8(8):e3110
pubmed: 25166475
Infect Immun. 2003 Jul;71(7):4026-33
pubmed: 12819091
Environ Monit Assess. 2018 Mar 3;190(4):188
pubmed: 29502239
Appl Environ Microbiol. 1999 Dec;65(12):5451-8
pubmed: 10584003
Infect Immun. 2000 Jun;68(6):3696-703
pubmed: 10816530
Biopolymers. 2014 Jan;102(1):30-9
pubmed: 23896704
PLoS One. 2014 Oct 07;9(10):e108876
pubmed: 25290909
J Microbiol Biotechnol. 2019 Nov 28;29(11):1841-1851
pubmed: 31387343
Bacteriol Virusol Parazitol Epidemiol. 2007 Jul-Dec;52(3-4):139-47
pubmed: 19326727
J Feline Med Surg. 2012 Jun;14(6):399-404
pubmed: 22388575
FEMS Microbiol Lett. 1997 Aug 15;153(2):265-72
pubmed: 9271852
Nanomedicine. 2007 Mar;3(1):95-101
pubmed: 17379174
Vet Microbiol. 2007 Dec 15;125(3-4):350-4
pubmed: 17646062
J Inorg Biochem. 2006 Jul;100(7):1225-33
pubmed: 16563513
Biometals. 2009 Apr;22(2):235-42
pubmed: 18769871
Nanotechnology. 2005 Oct;16(10):2346-53
pubmed: 20818017
Biometals. 1998 Jan;11(1):27-32
pubmed: 9450315
Bioresour Technol. 2019 Dec;293:122036
pubmed: 31479857
Antiviral Res. 2003 May;58(3):265-71
pubmed: 12767474
J Infect Dev Ctries. 2019 Aug 31;13(8):768-772
pubmed: 32069264
J Antimicrob Chemother. 2001 Aug;48(2):203-8
pubmed: 11481289
J Med Microbiol. 2004 Aug;53(Pt 8):783-786
pubmed: 15272066
Aust Vet J. 2011 Sep;89(9):346-51
pubmed: 21864307
Cell. 2008 May 16;133(4):601-11
pubmed: 18485869
J Bacteriol. 1975 Nov;124(2):959-68
pubmed: 1184578
Biotechnol Adv. 2009 Jan-Feb;27(1):76-83
pubmed: 18854209
Zoonoses Public Health. 2013 Mar;60(2):149-53
pubmed: 22898261
Cell Microbiol. 2003 Apr;5(4):203-23
pubmed: 12675679
Antimicrob Agents Chemother. 2002 Nov;46(11):3394-400
pubmed: 12384341
Clin Microbiol Rev. 2011 Oct;24(4):633-54
pubmed: 21976602
Mycopathologia. 2009 Jun;167(6):355-6
pubmed: 19130293
Future Microbiol. 2011 Jan;6(1):85-102
pubmed: 21162638
Antimicrob Agents Chemother. 2006 Nov;50(11):3519-28
pubmed: 17065617
Clin Infect Dis. 2007 Nov 15;45(10):1255-65
pubmed: 17968818